$RLFTF RADNOR, PA / ACCESSWIRE / October 14, 2020
Post# of 653
(Total Views: 377)
Posted On: 10/14/2020 11:45:06 PM
$RLFTF RADNOR, PA / ACCESSWIRE / October 14, 2020 / NeuroRx, Inc., a clinical-stage pharmaceutical company developing small molecules for unmet medical needs, announced today that Chairman and CEO Jonathan C. Javitt, M.D., M.P.H., will present a company overview at 9 a.m. EDT on Thursday, Oct. 15, at the Fall Private Company Showcase hosted by Solebury Trout, BMO and Davis Polk.
Dr. Javitt will cover the latest news for RLF-100™, which is in clinical development for the treatment of respiratory failure related to COVID-19, as well as the other pipeline programs.
Dr. Javitt will cover the latest news for RLF-100™, which is in clinical development for the treatment of respiratory failure related to COVID-19, as well as the other pipeline programs.
(0)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ
Scroll down for more posts ▼